Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
0.6200
-0.0410 (-6.20%)
At close: Nov 19, 2026, 4:00 PM EST
0.6300
+0.0100 (1.61%)
After-hours: Nov 19, 2026, 5:01 PM EST
Pliant Therapeutics Employees
Pliant Therapeutics had 49 employees as of December 31, 2025. The number of employees decreased by 122 or 71.35% compared to the previous year. That makes Pliant Therapeutics the 35,158th largest employer in the world and 4,677th in the United States.
Employees
49
Change (1Y)
-122
Growth (1Y)
-71.35%
Revenue / Employee
n/a
Profits / Employee
-$1,844,184
Market Cap
38.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 49 | -122 | -71.35% |
| Dec 31, 2024 | 171 | 13 | 8.23% |
| Sep 30, 2024 | 166 | 7 | 4.40% |
| Jun 30, 2024 | 166 | 11 | 7.10% |
| Mar 31, 2024 | 158 | 22 | 16.18% |
| Dec 31, 2023 | 158 | 34 | 27.42% |
| Sep 30, 2023 | 159 | 45 | 39.47% |
| Jun 30, 2023 | 155 | 45 | 40.91% |
| Mar 31, 2023 | 136 | 35 | 34.65% |
| Dec 31, 2022 | 124 | 33 | 36.26% |
| Sep 30, 2022 | 114 | 24 | 26.67% |
| Jun 30, 2022 | 110 | 20 | 22.22% |
| Mar 31, 2022 | 101 | 11 | 12.22% |
| Dec 31, 2021 | 91 | 13 | 16.67% |
| Sep 30, 2021 | 90 | 20 | 28.57% |
| Jun 30, 2021 | 90 | 23 | 34.33% |
| Mar 31, 2021 | 90 | 28 | 45.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 77 |
| Connect Biopharma Holdings | 64 |
| Elicio Therapeutics | 33 |
| Oncolytics Biotech | 29 |
| iBio, Inc. | 23 |
| Gain Therapeutics | 21 |
| RenovoRx | 17 |
| Dogwood Therapeutics | 8 |
PLRX News
- 7 days ago - Pliant Therapeutics reports Q3 EPS (39c), consensus (37c) - TheFly
- 7 days ago - Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 7 days ago - Pliant Therapeutics Quarterly report: Q3 2026 - Filings
- 7 days ago - Pliant Therapeutics Earnings release: Q3 2026 - Filings
- 10 days ago - Pliant Therapeutics Announces Presentation of PLN-101095 Preclinical and Clinical Data at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer - GlobeNewsWire
- 21 days ago - Pliant Therapeutics Announces Presentations at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer - GlobeNewsWire
- 4 weeks ago - Pliant Therapeutics Appoints Craig Blanchette, Ph.D., as Senior Vice President, Research (siRNA) - GlobeNewsWire
- 4 weeks ago - Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026 - GlobeNewsWire